Ribosomal protein L17 pseudogene 38 (RPL17P38)

Ribosomal protein L17 pseudogene 38 (RPL17P38) is a non-protein-coding segment in the human genome. It represents a processed pseudogene resulting from the duplication and integration of the functional RPL17 gene but lacks the regulatory elements or coding potential required to produce a functional ribosomal protein[1]. Unlike RPL17, which is a structural component of the large 60S ribosomal subunit and essential for protein synthesis[4][7], RPL17P38 does not participate in cellular functions and is not considered a therapeutic target. Gene databases and product catalogs list it strictly as a pseudogene, with no associated proteins, pathways, or drug interaction profiles[1][2][3][6][9].\nRPL17P38 is not a canonical drug target, does not encode an active molecular or cellular function, and should not be considered for drug discovery, mechanistic study, or biomarker purposes. Any confusion may arise due to its similarity in name to the functional ribosomal protein L17 gene (RPL17), but only the latter is biologically and therapeutically relevant[1][4][7].

Other names

RPL17P38RPL17_22_1275

None (As a pseudogene, not targeted by drugs)